Association between Admission Serum 25-Hydroxyvitamin D Levels and Functional Outcome of Thrombolyzed Stroke Patients

Journal of Stroke and Cerebrovascular Diseases

Volumn 25, Issue 4, 2016, Pages 907-913

  Daumas, Anaïs ^a   Daubail, Benoit ^a   Legris, Nicolas ^a   Jacquin Piques, Agnès ^a   Sensenbrenner, Bénédicte ^a   Denimal, Damien ^a   Lemaire Ewing, Stéphanie ^a   Duvillard, Laurence ^a   Giroud, Maurice ^a   Béjot, Yannick ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

prognosis; Stroke; thrombolysis; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ALTEPLASE; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT; 25-HYDROXYVITAMIN D; TISSUE PLASMINOGEN ACTIVATOR; VITAMIN D;

ADULT; AGED; ANTICOAGULANT THERAPY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; CONFIDENCE INTERVAL; CONFOUNDING VARIABLE; CONTROLLED STUDY; DECOMPRESSIVE CRANIECTOMY; DECOMPRESSIVE HEMICRANIECTOMY; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; FIBRINOLYTIC THERAPY; FUNCTIONAL ASSESSMENT; FUNCTIONAL DISEASE; HOSPITAL ADMISSION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LACUNAR STROKE; MAJOR CLINICAL STUDY; MALE; MECHANICAL THROMBECTOMY; MIDDLE AGED; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; RANKIN SCALE; SERUM; STROKE PATIENT; TRANSIENT ISCHEMIC ATTACK; TREATMENT DURATION; UNIVARIATE ANALYSIS; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; AGE; ANALOGS AND DERIVATIVES; BLOOD; COMPLICATION; FOLLOW UP; INTRAVENOUS DRUG ADMINISTRATION; RETROSPECTIVE STUDY; STATISTICAL MODEL; STROKE; TREATMENT OUTCOME; VERY ELDERLY;

ADMINISTRATION, INTRAVENOUS; AGE FACTORS; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STROKE; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; VITAMIN D;

EID: 84961924009     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2016.01.005     Document Type: Article

References (20)

1. K.E. Poole, N. Loveridge, P.J. Barker, and et al. Reduced vitamin D in acute stroke Stroke 37 2006 243 245
2. S. Carda, C. Cisari, M. Invernizzi, and et al. Osteoporosis after stroke: a review of the causes and potential treatments Cerebrovasc Dis 28 2009 191 200
3. Y. Béjot Vitamin D: a target for improving post-stroke prognosis? Eur J Neurol 22 2015 1247 1248 10.1111/000012635
4. B. Daubail, A. Jacquin, J.C. Guilland, and et al. Serum 25-hydroxyvitamin D predicts severity and prognosis in stroke patients Eur J Neurol 20 2013 57 61
5. Wang Y., Ji H., Tong Y., and et al. Prognostic value of serum 25-hydroxyvitamin D in patients with stroke Neurochem Res 39 2014 1332 1337
6. Han B., Y. Lyu, Sun H., and et al. Low serum levels of vitamin D are associated with post-stroke depression Eur J Neurol 22 2014 1269 1274 10.1111/000012607
7. B. Daubail, A. Jacquin, J.C. Guilland, and et al. Association between serum concentration of vitamin D and 1-year mortality in stroke patients Cerebrovasc Dis 37 2014 364 367
8. WHO The World Health Report 2000: health systems improving performance 2000 WHO Geneva
9. Haute Autorité de Santé Accident vasculaire cérébral: prise en charge précoce (alerte, phase préhospitalière, phase hospitalière initiale, indications de la thrombolyse) HAS/Service des bonnes pratiques professionnelles/Mai http://www.has-sante.fr/portail/upload/docs/application/pdf/2009-07/avc-prise-en-charge-precoce-recommandations.pdf 2009 Accessed January 21, 2016
10. H.P. Adams Jr, B.H. Bendixen, L.J. Kappelle, and et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment Stroke 24 1993 35 41
11. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group Tissue plasminogen activator for acute ischemic stroke N Engl J Med 333 1995 1581 1587
12. D. Denimal, V. Ducros, T. Dupré, and et al. Agreement of seven 25-hydroxy vitamin D3 immunoassays and three high performance liquid chromatography methods with liquid chromatography tandem mass spectrometry Clin Chem Lab Med 52 2014 511 520
13. Tu W., Zhao S.J., Xu D.J., and et al. Serum 25-hydroxyvitamin D predicts the short-term outcomes of Chinese patients with acute ischaemic stroke Clin Sci (Lond) 126 2014 339 346
14. Li Y.C., Qiao G., M. Uskokovic, and et al. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure J Steroid Biochem Mol Biol 89-90 2004 387 392
15. S. Pilz, A. Tomaschitz, C. Drechsler, and et al. Vitamin D supplementation: a promising approach for the prevention and treatment of strokes Curr Drug Targets 12 2011 88 96
16. L. Harling, S. Rasoli, J.A. Vecht, and et al. Do antioxidant vitamins have an anti-arrhythmic effect following cardiac surgery? A meta-analysis of randomized controlled trials Heart 97 2001 1636 1642
17. Wang Y., Y.H. Chiang, Su T.P., and et al. Vitamin D3 attenuates cortical infarction induced by middle cerebral arterial ligation in rats Neuropharmacology 39 2000 873 880
18. Won S., S. Iqbal, B.L. Peterson, and et al. Vitamin D prevents hypoxia/reoxygenation-induced blood-brain barrier disruption via vitamin D receptor-mediated NF-κB signaling pathways PLoS ONE 10 2015 e0122821
19. Mao P.J., Zhang C., Tang L., and et al. Effect of calcium or vitamin D supplementation on vascular outcomes: a meta-analysis of randomized controlled trials Int J Cardiol 169 2013 106 111
20. J.E. Manson, S.S. Bassuk, I.M. Lee, and et al. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease Contemp Clin Trials 33 2012 159 171